A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.

NCT06827457 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Disease

Interventions

DRUG: GenSci120
DRUG: Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.